IN2012DN01863A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01863A
IN2012DN01863A IN1863DEN2012A IN2012DN01863A IN 2012DN01863 A IN2012DN01863 A IN 2012DN01863A IN 1863DEN2012 A IN1863DEN2012 A IN 1863DEN2012A IN 2012DN01863 A IN2012DN01863 A IN 2012DN01863A
Authority
IN
India
Prior art keywords
taurine
lowering
composition
active ingredient
uric acid
Prior art date
Application number
Other languages
English (en)
Inventor
Fuminori Kimura
Hideaki Kitajima
Takao Tanaka
Toru Nishikawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of IN2012DN01863A publication Critical patent/IN2012DN01863A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1863DEN2012 2009-09-17 2010-09-10 IN2012DN01863A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009215092 2009-09-17
PCT/JP2010/065627 WO2011034006A1 (ja) 2009-09-17 2010-09-10 血液中の尿酸値を低下させるための組成物

Publications (1)

Publication Number Publication Date
IN2012DN01863A true IN2012DN01863A (es) 2015-07-17

Family

ID=43758611

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1863DEN2012 IN2012DN01863A (es) 2009-09-17 2010-09-10

Country Status (9)

Country Link
US (1) US9101588B2 (es)
JP (1) JP6112767B2 (es)
KR (1) KR20120068006A (es)
CN (1) CN102655862A (es)
IN (1) IN2012DN01863A (es)
MX (1) MX2012003290A (es)
SG (1) SG10201405790UA (es)
TW (1) TW201116275A (es)
WO (1) WO2011034006A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013018706A1 (ja) * 2011-08-03 2015-03-05 大正製薬株式会社 Urat1活性を調節するための組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006213607A (ja) 2005-02-01 2006-08-17 Asahi Breweries Ltd 尿酸値低下剤

Also Published As

Publication number Publication date
JP6112767B2 (ja) 2017-04-12
WO2011034006A1 (ja) 2011-03-24
JPWO2011034006A1 (ja) 2013-02-14
SG10201405790UA (en) 2014-11-27
CN102655862A (zh) 2012-09-05
MX2012003290A (es) 2012-04-30
US20120190886A1 (en) 2012-07-26
US9101588B2 (en) 2015-08-11
TW201116275A (en) 2011-05-16
KR20120068006A (ko) 2012-06-26

Similar Documents

Publication Publication Date Title
UA104203C2 (en) Microbiocidal heterocycles
MY183312A (en) Pharmaceutical formulation
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
MY158982A (en) Heterocyclic compound
EA201190227A1 (ru) Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ
TN2012000248A1 (en) Novel spiropiperidine compounds
WO2009041705A3 (en) 5-membered heterocyclic compounds as proton pump inhibitors
EP2432774A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING URIC ACID RATES
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
MY169734A (en) Methods for improving pharmacokinetics
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2012004087A (es) Sulfonamidas para la prevencion de diabetes.
MX2014005399A (es) Metodos para tratar gota en sub-poblaciones de pacientes.
IN2012DN01863A (es)
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi
MX2013002656A (es) Nuevo proceso.
WO2011161295A3 (es) Uso de compuestos anticalcineurina para el tratamiento de patologías que cursan con neovascularización ocular
UA38601U (en) 2,2'-dithioxo-4,4'-dioxo-[5,5']-bithiazolidinyl-idene-diyl-3,3'-dibutanoic acid diarylamides having antitumor activity
UA44364U (ru) Соединение 2-(n-ортохлорфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность
UA44361U (ru) Соединение 2-(n-параметилфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность
UA94136C2 (ru) Н-бутиламид 4-метил-7-хлор-2-оксо-1,2-дигмдрохинолин-6-сульфоновой кислоты, проявляющий диуретическую активность
UA42369U (ru) Соединение 2-( n-параморфолинофенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность
UA42370U (ru) Соединение 2-( n-ортотрифторметилфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность